Literature DB >> 1666264

Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues.

H S Ahn1, M Foster, M Cable, B J Pitts, E J Sybertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1666264     DOI： 10.1007/978-1-4684-6015-5_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  15 in total

1.  Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports.

Authors:  Ikuko Hayakawa; Fumiaki Shirasaki; Takashi Hirano; Naoto Oishi; Minoru Hasegawa; Shinichi Sato; Kazuhiko Takehara
Journal:  Rheumatol Int       Date:  2005-05-25       Impact factor: 2.631

2.  Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis.

Authors:  Puneeta Tandon; Irteza Inayat; Michael Tal; Marcelo Spector; Martha Shea; Roberto J Groszmann; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-06       Impact factor: 11.382

Review 3.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  A pilot study of the effects of sildenafil on stool characteristics, colon transit, anal sphincter function, and rectal sensation in healthy men.

Authors:  Mark Milone; John K DiBaise
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

5.  Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.

Authors:  Ying-Wen Wang; Han-Chieh Lin; Ying-Ying Yang; Ming-Chih Hou; Shou-Dong Lee
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

6.  Phosphodiesterase-5 activity exerts a coronary vasoconstrictor influence in awake swine that is mediated in part via an increase in endothelin production.

Authors:  Zhichao Zhou; Vincent J de Beer; Shawn B Bender; A H Jan Danser; Daphne Merkus; M Harold Laughlin; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

7.  Role of phosphodiesterases in modulation of BKCa channels in hypertensive pulmonary arterial smooth muscle.

Authors:  Shu Zhu; Richard E White; Scott A Barman
Journal:  Ther Adv Respir Dis       Date:  2008-06       Impact factor: 4.031

8.  PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.

Authors:  Sabrina Noel; Barbara Dhooghe; Teresinha Leal
Journal:  Front Pharmacol       Date:  2012-09-18       Impact factor: 5.810

9.  Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy.

Authors:  Yu-Chun Lin; Steve Leu; Cheuk-Kwan Sun; Chia-Hung Yen; Ying-Hsien Kao; Li-Teh Chang; Tzu-Hsien Tsai; Sarah Chua; Morgan Fu; Sheung-Fat Ko; Chiung-Jen Wu; Fan-Yen Lee; Hon-Kan Yip
Journal:  J Transl Med       Date:  2010-09-26       Impact factor: 5.531

10.  Sidenafil pre-treatment promotes decompression sickness in rats.

Authors:  Jean-Eric Blatteau; Alf O Brubakk; Emmanuel Gempp; Olivier Castagna; Jean-Jacques Risso; Nicolas Vallée
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.